Financial statements Fortis Pharmaceuticals
Balance sheet of Fortis Pharmaceuticals
Company age:
Age:
4 y. 5 m. 11 d.
Share capital:
Share capital:
20 000 PLN
Balance sheet data of FORTIS PHARMACEUTICALS
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 4 050 325,68 | 5 725 226,99 | 6 779 177,69 |
| A. Fixed assets | 227 949,89 | 227 383,22 | 74 968,70 |
| B. Current assets | 3 822 375,79 | 5 497 843,77 | 6 704 208,99 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 4 050 325,68 | 5 725 226,99 | 6 779 177,69 |
| A. Equity | 2 068 211,70 | 1 352 380,26 | 3 109 402,93 |
| B. Liabilities and provisions for liabilities | 1 982 113,98 | 4 372 846,73 | 3 669 774,76 |
| I. Long-term liabilities | 570 000,00 | 700 000,00 | 0,00 |
| II. Short-term liabilities | 1 412 113,98 | 3 671 747,82 | 3 654 702,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.